论文部分内容阅读
目的研究添加马来酸桂哌齐特治疗急性脑梗死的临床疗效。方法将90例急性脑梗死患者随机分成对照组和治疗组,每组45例,对照组采用急性脑梗死的常规药物治疗,治疗组在对照组常规治疗的基础上给予马来酸桂哌齐特静脉滴注,14 d后观察其疗效。结果经14 d的治疗后治疗组与对照组的神经功能缺损评分、日常生活能力评分及临床疗效比较差异有统计学意义(P<0.05)。结论在常规药物治疗基础上加用马来酸桂哌齐特可有效改善急性脑梗死患者的神经功能缺损情况,提高日常生活能力,疗效确切。
Objective To study the clinical efficacy of cinepazide maleate in the treatment of acute cerebral infarction. Methods Ninety patients with acute cerebral infarction were randomly divided into control group and treatment group, with 45 cases in each group. The control group was given routine drug treatment of acute cerebral infarction. The treatment group was given cinepazide maleate Intravenous drip, 14 days after the observation of its efficacy. Results After 14 days of treatment, the neurological deficit score, daily living ability score and clinical curative effect were significantly different between the treatment group and the control group (P <0.05). Conclusion The addition of cinepazide maleate to conventional drug therapy can effectively improve the neurological deficit in patients with acute cerebral infarction and improve the daily living ability, and the curative effect is definite.